RAC1 and central nervous system cancer: Both in LN229 and U-87 glioma cell lines, it specifically inhibited the activation of RAC1 [13], a monomeric GTPase involved in a variety of cellular processes required for tumor progression (proliferation, migration, and cytoskeleton reorganization) [15,16].